Research article · 30 Jan 2013
EditorialPublished 2014
Lixisenatide: A New Glucagon-Like Peptide-1 Agonist
Subjects
Pharmaceutical SciencesSimilar by topic
Other · 4 Jan 2021
Controlled release of pyrimidine compound using polymeric coated zif-8 metal-organic framework as glucagon-like peptide-1 receptor agonist carrier
Research article · 26 Aug 2023
Establishment of Stability-Indicating Purity Method Based on the Stress Degradation Behaviour of Human Glucagon-like Peptide-1 Analog Liraglutide using Reverse Phase-Liquid Chromatography
Research article · 14 Jul 2022
Clinical Efficacy Evaluation and Long-Term Prognosis of Glucagon-Like Peptide-1 Combined with Sodium Glucose Cotransporter-2 Inhibitor in Diabetes
Review article · 2020
The Effect of Annona Muricata Leaf Ethanolic Extract on Insulin Expression and Glucagon-Like Peptide-1 Level in Alloxan-Induced Mice
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Christopher W Ho”

